Radioprotective effects of serum thymic factor in mice.
Serum thymic factor (FTS) reduced mortality of mice after total-body irradiation with 7.56 Gy X rays. The radioprotective effect was achieved by daily repeated subcutaneous injections of 3-100 micrograms FTS, while doses higher than 300 micrograms/day/mouse were neither radioprotective nor toxic. Similarly, degeneration of the spleen was moderated by 3-100 micrograms FTS but not by 500 micrograms FTS in sublethally (3.78 Gy) irradiated mice. Histological examination showed that hematopoiesis was enhanced in the spleen by daily injections of 10 micrograms FTS. Spleen cells from the FTS-treated mice incorporated more [3H]thymidine in culture with or without concanavalin A. The treatment with FTS increased the production of colony-stimulating factor in the spleen as well as in peritoneal macrophage-like cells, and caused a significant increase in the number of granulocyte-macrophage colony-forming cells both in the spleen and in the femoral bone marrow. Furthermore, FTS prevented a decrease in circulating neutrophils in the sublethally irradiated mice. Prominent overshoot recovery of myelopoiesis, which occurred occasionally in sublethally irradiated mice, did not occur in the FTS-treated mice. The decrease in blood erythrocytes was also significantly reduced. These observations imply that this thymic hormone has potential as a radioprotector.
Kobayashi
H
H
Institute of Biological Science, Mitsui Pharmaceuticals Inc., Mobara, Japan.
Abe
H
H
Ueyama
T
T
Awaya
A
A
Shikita
M
M
D000818:Animals; D007279:Injections, Subcutaneous; D007958:Leukocyte Count / Q000187:drug effects / Q000528:radiation effects; D008297:Male; D051379:Mice; D008809:Mice, Inbred C3H; D011833:Radiation Injuries, Experimental / Q000097:blood / Q000134:cerebrospinal fluid / Q000517:prevention & control*; D011837:Radiation-Protective Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D013158:Splenic Diseases / Q000097:blood / Q000134:cerebrospinal fluid / Q000517:prevention & control; D013935:Thymic Factor, Circulating / Q000008:administration & dosage / Q000627:therapeutic use*; D014916:Whole-Body Irradiation
D011837:Radiation-Protective Agents; D013935:Thymic Factor, Circulating